Skip to contentApplication 021149
- Type
- BLA
- Sponsor
- EMD SERONO
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | OVIDREL | CHORIOGONADOTROPIN ALFA | INJECTABLE;INJECTION | 0.25MG/VIAL | No | No |
| 002 | OVIDREL | CHORIOGONADOTROPIN ALFA | INJECTABLE;SUBCUTANEOUS | EQ 0.25MG /0.5ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 44087-1150 | Ovidrel | choriogonadotropin alfa | EMD Serono, Inc. | BLA | Current |
| 44087-1150 | Ovidrel | choriogonadotropin alfa | EMD Serono, Inc. | BLA | Current |
| 44087-1150 | Ovidrel | choriogonadotropin alfa | EMD Serono, Inc. | NDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 62244 | APPL | 2020-03-23 |
| 41985 | ORIG | 2020-03-23 |
| 26908 | SUPPL | 2020-03-23 |
| 26907 | SUPPL | 2020-03-23 |
| 14504 | SUPPL | 2020-03-23 |
| 14503 | SUPPL | 2020-03-23 |
| 14502 | ORIG | 2020-03-23 |
| 4472 | SUPPL | 2020-03-23 |
| 4471 | ORIG | 2020-03-23 |